Non-rebreathing Oxygen Mask Market Size, Share and Global Trend By Age Group (Paediatric, Adult), By End User (Hospital & Trauma Centers, Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
A Non-rebreathing oxygen mask is used for the delivery of high oxygen concentration via a face mask containing a reservoir bag that allows adequate oxygen to be available for the unpredicted breathing pattern of the patient and tidal volume. Smoking remains one of the major risk factors for breathing or respiratory disorders; other factors include infections, occupational factors, and rising air pollution.
According to the Global Burden of Disease Study conducted by the World Health Organization, in 2016, the prevalence of chronic obstructive pulmonary disease (COPD) was 251 million. As per the reports of WHO, the prevalence of Asthma in the world has increased in the last 40 years because of the adoption of modern lifestyle, and approximately 100 million people will be added by 2025. The increasing episodes of emergency visits requiring Cardiopulmonary Resuscitation (CPR) have boosted the demand for the non-rebreathing oxygen mask.
To gain extensive insights into the market, Request for Customization
The growth in global non-rebreathing oxygen market is being driven by the increase in chronic respiratory diseases such as asthma, pulmonary hypertension, respiratory allergies, chronic obstructive pulmonary diseases (COPD), and many others. Also, the rise in trauma cases due to road traffic accidents is also driving the global non-rebreathing oxygen market. According to World Health Organization, a total number of deaths from chronic obstructive pulmonary disease (COPD) is forecasted to increase by more than 30% in the next ten years, resulting in chronic obstructive pulmonary disease (COPD) becoming the third leading cause of death worldwide by 2030.
However, a non-rebreathing oxygen mask is not effective in long term treatment, and malfunction can result in carbon dioxide build-up, which are the factors that can hamper the growth in the global non-rebreathing oxygen market.
Key Players Covered
Some of the major companies that are present in the global non-rebreathing oxygen mask market are Philips Respironics Inc, Intersurgical Inc., Smiths Group plc. (Smiths Medical), Fisher & Paykel Healthcare Limited, MAQUET Holding B.V. & Co. KG, CareFusion Corporation, DeVilbiss Healthcare LLC. Savvy, ResMed, Invacare Corporation, Teleflex Incorporated, Allied Healthcare Products, and other players.
SEGMENTATION
SEGMENTATION | DETAILS |
By Age Group | · Paediatric · Adult |
By End-User | · Hospital & Trauma Centers · Specialty Clinics · Ambulatory Surgical Centers · Home Healthcare · Others |
By Geography | · North America (the USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa) |
Among the end-user, the hospital & trauma centers segment is anticipated to dominate the global non-rebreathing oxygen mask market owing to the increased number of emergency visits and high volume usage of oxygen masks.
Key Insights
- Prevalence of chronic respiratory diseases for key countries
- Overview of regulatory guidelines for non-rebreathing oxygen masks, for key countries
- Recent industry developments such as partnerships, mergers, and acquisitions
Regional Analysis
North America is esteemed to showcase an exponential growth in the global non-rebreathing oxygen mask market during the forecast period owing to the rise in air pollution and improvement in health infrastructure. The non-rebreathing oxygen mask market in Europe is projected to expand by 2026, owing to the increasing respiratory disorders in Europe. According to the European Lung Foundation, 600,000 people are affected by respiratory diseases every year in Europe, which is estimated to boost the growth of non-rebreathing oxygen masks market in this region.
Key Industry Developments
- In October 2015, Thoracic Society of Australia and New Zealand released clinical practice Oxygen Guidelines for Acute Oxygen Use in Adults recommending the use of non-rebreathing oxygen mask.
- In October 2017, Xiamen Compower Medical Tech. Co. Ltd. received FDA 510(k) approval for Non-Rebreathing Valve of 15mmOD) and 18.5mm.
- In March 2018, POM Medical, LLC received FDA 510(k) approval for Panoramic Oxygen Mask (POM) used for delivery of supplemental oxygen.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
